CONMED Valuation
Is CNMD * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CNMD * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CNMD * (MX$1454) is trading below our estimate of fair value (MX$2384.58)
Significantly Below Fair Value: CNMD * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CNMD *?
Key metric: As CNMD * is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is CNMD *'s PE Ratio? | |
|---|---|
| PE Ratio | 16.7x |
| Earnings | US$131.74m |
| Market Cap | US$2.20b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.4x |
| Enterprise Value/EBITDA | 14.2x |
| PEG Ratio | 1.2x |
Price to Earnings Ratio vs Peers
How does CNMD *'s PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 43x | ||
EKTA B Elekta | 21.1x | 17.9% | SEK 24.2b |
LMAT LeMaitre Vascular | 55.5x | 12.2% | US$2.3b |
EMBLA Embla Medical hf | 30.8x | 16.9% | DKK 15.1b |
300633 SonoScape Medical | 64.5x | 54.7% | CN¥15.7b |
CNMD * CONMED | 16.7x | 13.8% | Mex$2.2b |
Price-To-Earnings vs Peers: CNMD * is good value based on its Price-To-Earnings Ratio (16.7x) compared to the peer average (43x).
Price to Earnings Ratio vs Industry
How does CNMD *'s PE Ratio compare vs other companies in the Global Medical Equipment Industry?
| 9 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 9 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: CNMD * is good value based on its Price-To-Earnings Ratio (16.7x) compared to the Global Medical Equipment industry average (27.6x).
Price to Earnings Ratio vs Fair Ratio
What is CNMD *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 16.7x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CNMD *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Médica Sur. de
Mex$3.0b
Operates as a healthcare hospital in Mexico.
MEDICA B
Mex$29.00
7D
-3.3%
1Y
-30.6%
ZimVie
US$186.2m
Develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide.
ZIMV *
US$230.00
7D
0%
1Y
n/a
M3
JP¥880.0b
Provides medical-related services primarily to physicians and other healthcare professionals through Internet.
2413 N
JP¥183.50
7D
0%
1Y
n/a